Abstract:
An E.coli expression vector of neuraminidase N1 of avian influenza (AI) is provided to quickly and massively produce AI virus neuraminidase N1 and select an inhibitor of AI virus neuraminidase N1 as a therapeutic agent. A vector for expressing neuraminidase N1 of avian influenza (AI) in E.coli comprises a neuraminidase N1 gene of avian influenza (AI) in multiple cloning site of pET-23d vector. A method for producing the neuraminidase N1 gene of avian influenza (AI) comprises: a step of transforming E.coli with the vector which expresses the neuraminidase N1; and a step of culturing the transformed E.coli.